BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026)
BridgeBio Pharma (BBIO) posted Other financing activities of $5.5 million for Q1 2026, up 144.18% sequentially from -$12.4 million in Q4 2025, and up 583.25% YoY from $800000.0 in Q1 2025.
BridgeBio Pharma (BBIO) Other financing activities (2018 - 2026) Analysis & Trends
BridgeBio Pharma has reported Other financing activities for 9 years, with the latest figure at $5.5 million in Q1 2026.
- Quarterly Other financing activities rose 583.25% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 2491.63% YoY) and the FY2025 annual result came in at $2.2 million, changed N/A from the prior year.
- Other financing activities climbed to $5.5 million in Q1 2026 per BBIO's latest filing, from -$12.4 million in the prior quarter.
- Over five years, Other financing activities peaked at $11.3 million in Q3 2025 and troughed at -$12.4 million in Q4 2025.
- A 5-year average of $585812.5 and a median of $668500.0 in 2024 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 37520.0% in 2025, down 1431.31% in 2025.
- Over 5 years, Other financing activities stood at $2.6 million in 2022, then slumped by 264.11% to -$4.2 million in 2023, then soared by 80.75% to -$808000.0 in 2024, then plunged by 1431.31% to -$12.4 million in 2025, then soared by 144.18% to $5.5 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $5.5 million, -$12.4 million, and $11.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.22 Mn |
| Jun 30, 2026 | 5.22 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | -12.37 Mn |
| Dec 31, 2025 | -12.37 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 800,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Mar 31, 2024 | 537,000.00 |